Drug Profile
ELND 006
Alternative Names: ELND006Latest Information Update: 01 Nov 2010
Price :
$50
*
At a glance
- Originator Elan Pharmaceuticals
- Class Antidementias; Small molecules
- Mechanism of Action Amyloid precursor protein secretase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease
Most Recent Events
- 28 Oct 2010 Discontinued - Phase-I for Alzheimer's disease in USA (unspecified route)